Tapazole (Methimazole) - Summary

TAPAZOLE SUMMARY

Tapazole^®
Methimazole Tablets, USP

Tapazole^® (Methimazole Tablets, USP) is an orally administered antithyroid drug.

Each tablet contains 5 or 10 mg (43.8 or 87.6 µmol) of methimazole.

Tapazole is indicated in the medical treatment of hyperthyroidism. Long-term therapy may lead to remission of the disease. Tapazole may be used to ameliorate hyperthyroidism in preparation for subtotal thyroidectomy or radioactive iodine therapy. Tapazole is also used when thyroidectomy is contraindicated or not advisable.

TAPAZOLE NEWS HIGHLIGHTS

Published Studies Related to Tapazole (Methimazole)

Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. [2007.06]

Continuous methimazole therapy and its effect on the cure rate of hyperthyroidism using radioactive iodine: an evaluation by a randomized trial. [2006.08]

Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine. [2005.05]

Serum thyrotropin-receptor autoantibodies levels after I therapy in Graves' patients: effect of pretreatment with methimazole evaluated by a prospective, randomized study. [2004.10]

Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. [2004.06]

more>>

Clinical Trials Related to Tapazole (Methimazole)

Methimazole to Treat Polymyositis and Dermatomyositis [Completed]

Antithyroid Drugs During Radioiodine Therapy [Completed]

Block-Replacement Therapy During Radioiodine Therapy [Recruiting]

Rituximab in the Treatment of Graves' Disease [Completed]

Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT [Recruiting]

more>>